The Effect of Interleukin-1 on Venous Endothelium – An Ultrastructural Study

Summary

The effect of systemic interleukin-1 (IL-1) on venous endothelium in the presence and absence of stasis has been studied by scanning electron microscopy (SEM). Recombinant human IL-1β at a concentration of 1 εg/kg or saline was injected intravenously into rabbits and allowed to circulate for 0.5 or 4.0 h after which complete stasis was induced for 1 h in an isolated segment of each jugular vein. One vein segment was then excised and the contents examined macroscopically for thrombi, while the other segment was fixed for SEM examination. When examined by SEM the endothelium from rabbits injected with IL-1β was perturbed with increased surface microvilli, blebs and gaps at cell junctions when compared with saline controls. Fibrin deposition was also observed after IL-1β, as was the adherence of essentially non-activated platelets to intact endothelium. However, macroscopic thrombi were not formed in isolated vein segments. We conclude that although fibrin strands and platelets were deposited on the endothelium, IL-1 is not a sufficiently powerful procoagulant stimulus to lead to an occlusive thrombus in acute experiments.

• References

• 1 Hewson W. An Experimental Inquiry into the Properties of the Blood. Cadell, London: 1771. p 20
• 2 Lister J. On the coagulation of the blood. Proc R Soc 1863; 12: 580-611
• 3 Wessler S, Reimer SM, Sheps MC. Biologic assay of a thrombosis-inducing activity in human serum. J Appl Physiol 1959; 14: 943-6
• 4 March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D. Cloning, sequence and expression of 2 distinct human interleukin-1 complementary DNAs. Nature 1985; 315: 641-6
• 5 Dower SK, Kronheim SR, Hopp TP, Cantrell M, Deeley M, Gillis S, Henney CS, Urdal DL. The cell surface receptors for Interleukin-1α and Interleukin-1β are identical. Nature 1986; 324: 261-8
• 6 Poole S, Bristow AF, Selkirk S, Rafferty B. Development and application of radioimmunoassays for Interleukin-lα and Interleukin-1β. J Immunol Methods 1989; 116: 259-64
• 7 Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci 1986; 83: 3460-4
• 8 Dejana E, Ji-Ming W, Mantovani A. The recruitment of leucocytes and their interaction with the vessel wall: the role of Interleukin 1 and Tumor Necrosis Factor. Scand J Rheumatol 1987; suppl 66 19-25
• 9 Breviario F, Bertocchi F, Dejana E, Bussolino F. IL-1 induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells; role of platelet-activating factor. J Immunol 1988; 141 (10) 3391-7
• 10 Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1989; 83: 444-55
• 11 Dunn CJ, Schaub RG, Fleming WE, Gibbons AJ. Interleukin-1 induced vascular pathology "in vivo": a scanning electron-microscopy study. Agents and Actions 1989; 27 (3/4) 287-9
• 12 Thomas DP, Merton RE, Hockley DJ. The effect of stasis on the venous endothelium: an ultrastructural study. Br J Haematol 1983; 55: 113-22
• 13 Thomas DP, Merton RE, Hiller KF, Hockley D. Resistance of normal endothelium to damage by thrombin. Br J Haematol 1982; 51: 25-35
• 14 Thomas DP, Merton RE, Wood RD, Hockley DJ. The relationship between vessel wall injury and venous thrombosis: an experimental study. Br J Haematol 1985; 59: 449-57
• 15 Mills DCB. The mechanism of action of antiplatelet drugs. In: Haemostasis and Thrombosis.. Colman R, Hirsh J, Marder V, Salzman E. (eds) 2nd ed. Lippincott: 1982. p 1058
• 16 Bussolino F, Breviario F, Tetta C, Aglietta M, Mantovani A, Dejana E. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest 1986; 77: 2027-33
• 17 Mantovani A, Dejana E. Modulation of endothelial function by interleukin-1: a novel target for pharmacological intervention. Biochem Pharmacol 1987; 36: 301
• 18 Callahan KS, Wallis WJ, Harlan JM. Interleukin 1 (IL-1) stimulates prostacyclin (PGI₂) release from cultured human endothelial cells. Thromb Haemostas 1985; 54: 110 (Abstr no 0649)
• 19 Stern DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988; 18: 202-14
• 20 Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-6
• 21 Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ. Cytokine activation of vascular endothelium. J Biol Chem 1988; 263 (12) 5797-803
• 22 Gitel SN, Stephenson RC, Wessler S. In vitro and in vivo correlation of clotting protease activity: effect of heparin. Proc Natl Acad Sci USA 1977; 74: 3028-32
• 23 Thomas DP, Wessler S. Stasis thrombi induced by bacterial endotoxin. Circ Res 1964; 14: 486-93
• 24 Eastgate JA, Wood NC, di Giovine FS, Symono JA, Grinlinton FM, Duff GW. Correlation of plasma Interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 706-9
• 25 di Giovine FS, Poole S, Situnayake RD, Wadhwa M, Duff GW. Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int 1990; 9: 259-64